André van der Westhuizen

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Solvent Production and Morphological Changes in <i>Clostridium acetobutylicum</i>

David T. Jones, André van der Westhuizen, Susan K. De Long et al. · Applied and Environmental Microbiology · 1982 · 174 citations · Full text

Life Sciences, Microbiology, Industrial Microbiology +15

Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)

Jeffrey S. Weber, Dirk Schadendorf, Michele Del Vecchio et al. · Journal of Clinical Oncology · 2022 · 162 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Marco Colleoni, Weixiu Luo, Per Karlsson et al. · The Lancet Oncology · 2017 · 122 citations

Medicine, Gynecology, Oncology +13

CFD–DEM modelling of particle flow in IsaMills – Comparison between simulations and PEPT measurements

C.T. Jayasundara, Runyu Yang, Bingjing Guo et al. · Minerals Engineering · 2010 · 77 citations

Engineering, Computational Engineering, Aerodynamics +7